default author photo

Fenneke Zwierenga

University of Groningen - Department of Pulmonology

Groningen

Netherlands

  • University of Groningen - Department of Pulmonology

SCHOLARLY PAPERS

1

DOWNLOADS

89

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

High Dose Osimertinib in Patients with Advanced Stage EGFR Exon 20 Mutation-Positive NSCLC: Results from the Phase 2 Multicenter POSITION20 Trial

Number of pages: 21 Posted: 25 Feb 2022
Fenneke Zwierenga, Bianca van Veggel, Lizza E.L. Hendriks, T.Jeroen N. Hiltermann, Birgitta I. Hiddinga, Lucie B.M. Hijmering – Kappelle, Arja ter Elst, Sayed M.S. Hashemi, A-M.C. Dingemans, Cor van der Leest, Adrianus J. de Langen, Michel van den Heuvel and Anthonie J. van der Wekken
University of Groningen - Department of Pulmonology, affiliation not provided to SSRN, Maastricht University, University of Groningen - Department of Pulmonary Diseases, affiliation not provided to SSRN, University of Groningen - University Medical Center Groningen, affiliation not provided to SSRN, affiliation not provided to SSRN, Erasmus University Rotterdam, Amphia Hospital, Netherlands Cancer Institute, Radboud University Nijmegen - Department of Pulmonary Diseases and University of Groningen - University Medical Center Groningen
Downloads 89 (753,595)

Abstract:

Loading...

Non-small cell lung cancer, epidermal growth factor receptor, tyrosine kinase inhibitors, exon 20 mutation, Osimertinib